eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
4/2014
vol. 6
 
Share:
Send email
Share:
abstract:

Review paper
Clinical implementation of a new electronic brachytherapy system for skin brachytherapy

Olga Pons-Llanas
,
Rosa Ballester-Sánchez
,
Francisco Javier Celada-Álvarez
,
Cristian Candela-Juan
,
Teresa García-Martínez
,
Margarita Llavador-Ros
,
Rafael Botella-Estrada
,
Christopher A. Barker
,
Antonio Ballesta
,
Alejandro Tormo-Micó
,
Silvia Rodríguez
,
Jose Perez-Calatayud

J Contemp Brachytherapy 2014; 6, 4: 417–423
DOI: https://doi.org/10.5114/jcb.2014.47996
Online publish date: 2014/12/31
View full text Get citation
 
Although surgery is usually the first-line treatment for nonmelanoma skin cancers, radiotherapy (RT) may be indicated in selected cases. Radiation therapy as primary therapy can result in excellent control rates, cosmetics, and quality of life. Brachytherapy is a radiation treatment modality that offers the most conformal option to patients. A new modality for skin brachytherapy is electronic brachytherapy. This involves the placement of a high dose rate X-ray source directly in a skin applicator close to the skin surface, and therefore combines the benefits of brachytherapy with those of low energy X-ray radiotherapy. The Esteya electronic brachytherapy system is specifically designed for skin surface brachytherapy procedures. The purpose of this manuscript is to describe the clinical implementation of the new Esteya electronic brachytherapy system, which may provide guidance for users of this system. The information covered includes patient selection, treatment planning (depth evaluation and margin determination), patient marking, and setup. The justification for the hypofractionated regimen is described and compared with others protocols in the literature. Quality assurance (QA) aspects including daily testing are also included. We emphasize that these are guidelines, and clinical judgment and experience must always prevail in the care of patients, as with any medical treatment. We conclude that clinical implementation of the Esteya brachytherapy system is simple for patients and providers, and should allow for precise and safe treatment of nonmelanoma skin cancers.
keywords:

basal cell carcinoma, electronic brachytherapy, Esteya, fractionation, patient setup, skin cancer

  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.